Nanoplasmonic Biosensors are advanced devices that leverage the unique optical properties of plasmonic nanoparticles for highly sensitive and label-free detection of biological molecules. These sensors operate based on the principle of surface plasmon resonance (SPR), where the interaction of light with free electrons at the surface of metallic nanoparticles induces a resonance condition that is highly sensitive to changes in the local refractive index. In nanoplasmonic biosensors, commonly used metals like gold and silver are structured into nanoscale geometries to enhance the surface plasmon resonance effect. Binding events, such as the attachment of biomolecules to the sensor surface, cause measurable shifts in the plasmon resonance frequency, enabling real-time monitoring of molecular interactions. The label-free nature of nanoplasmonic biosensors eliminates the need for fluorescent or radioactive labels, reducing assay complexity and increasing experimental efficiency. These sensors find applications in various fields, including medical diagnostics, environmental monitoring, and food safety. Nanoplasmonic biosensors offer exceptional sensitivity, enabling the detection of low concentrations of analytes, such as proteins, nucleic acids, and small molecules. Their miniaturized nature makes them suitable for integration into portable and point-of-care devices. Ongoing research in nanoplasmonics focuses on refining sensor designs, exploring novel materials, and expanding the range of detectable analytes. These biosensors hold great promise for advancing diagnostics, personalized medicine, and understanding molecular interactions at the nanoscale.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy